Literature DB >> 20590685

Induction of tolerance in clinical kidney transplantation.

Tatsuo Kawai1, A Benedict Cosimi.   

Abstract

Induction of donor-specific tolerance has been an ultimate goal in organ transplantation. Although numerous regimens for the induction of allograft tolerance have been developed in rodents, their application to primates has been limited. The approaches that have been successfully applied in primates can be divided into (i) use of total lymphoid irradiation, (ii) costimulatory blockade, (iii) profound depletion of recipient T cells, (iv) infusion of regulatory cells and (v) donor bone marrow (DBM) infusion/transplantation. Among these approaches, successful allograft tolerance has been achieved in clinical kidney transplantation using DBM transplantation.

Entities:  

Mesh:

Year:  2010        PMID: 20590685      PMCID: PMC4009987          DOI: 10.1111/j.1399-0012.2010.01268.x

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  39 in total

1.  Peritransplant tolerance induction in macaques: early events reflecting the unique synergy between immunotoxin and deoxyspergualin.

Authors:  J M Thomas; J L Contreras; X L Jiang; D E Eckhoff; P X Wang; W J Hubbard; A L Lobashevsky; W Wang; C Asiedu; S Stavrou; W J Cook; M L Robbin; F T Thomas; D M Neville
Journal:  Transplantation       Date:  1999-12-15       Impact factor: 4.939

2.  Induction therapy with monoclonal antibodies specific for CD80 and CD86 delays the onset of acute renal allograft rejection in non-human primates.

Authors:  A D Kirk; D K Tadaki; A Celniker; D S Batty; J D Berning; J O Colonna; F Cruzata; E A Elster; G S Gray; R L Kampen; N B Patterson; P Szklut; J Swanson; H Xu; D M Harlan
Journal:  Transplantation       Date:  2001-08-15       Impact factor: 4.939

Review 3.  Strategies to improve long-term outcomes after renal transplantation.

Authors:  Manuel Pascual; Tom Theruvath; Tatsuo Kawai; Nina Tolkoff-Rubin; A Benedict Cosimi
Journal:  N Engl J Med       Date:  2002-02-21       Impact factor: 91.245

4.  Clinical transplantation tolerance twelve years after prospective withdrawal of immunosuppressive drugs: studies of chimerism and anti-donor reactivity.

Authors:  S Strober; C Benike; S Krishnaswamy; E G Engleman; F C Grumet
Journal:  Transplantation       Date:  2000-04-27       Impact factor: 4.939

5.  Tolerogenic immunosuppression for organ transplantation.

Authors:  Thomas E Starzl; Noriko Murase; Kareem Abu-Elmagd; Edward A Gray; Ron Shapiro; Bijan Eghtesad; Robert J Corry; Mark L Jordan; Paulo Fontes; Tim Gayowski; Geoffrey Bond; Velma P Scantlebury; Santosh Potdar; Parmjeet Randhawa; Tong Wu; Adriana Zeevi; Michael A Nalesnik; Jennifer Woodward; Amadeo Marcos; Massimo Trucco; Anthony J Demetris; John J Fung
Journal:  Lancet       Date:  2003-05-03       Impact factor: 79.321

6.  CD154 blockade for induction of mixed chimerism and prolonged renal allograft survival in nonhuman primates.

Authors:  Tatsuo Kawai; Hiroshi Sogawa; Svetlan Boskovic; Gregory Abrahamian; Rex-Neal Smith; Siew-Lin Wee; David Andrews; Ognjenka Nadazdin; Ichiro Koyama; Megan Sykes; Henry J Winn; Robert B Colvin; David H Sachs; A Benedict Cosimi
Journal:  Am J Transplant       Date:  2004-09       Impact factor: 8.086

7.  Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era.

Authors:  Herwig-Ulf Meier-Kriesche; Jesse D Schold; Titte R Srinivas; Bruce Kaplan
Journal:  Am J Transplant       Date:  2004-03       Impact factor: 8.086

8.  Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease.

Authors:  Leo H Bühler; Thomas R Spitzer; Megan Sykes; David H Sachs; Francis L Delmonico; Nina Tolkoff-Rubin; Susan L Saidman; Robert Sackstein; Steven McAfee; Bimalangshu Dey; Christine Colby; A Benedict Cosimi
Journal:  Transplantation       Date:  2002-11-27       Impact factor: 4.939

9.  Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation.

Authors:  Maria T Millan; Judith A Shizuru; Petra Hoffmann; Sussan Dejbakhsh-Jones; John D Scandling; F Carl Grumet; Jane C Tan; Oscar Salvatierra; Richard T Hoppe; Samuel Strober
Journal:  Transplantation       Date:  2002-05-15       Impact factor: 4.939

10.  Results from a human renal allograft tolerance trial evaluating the humanized CD52-specific monoclonal antibody alemtuzumab (CAMPATH-1H).

Authors:  Allan D Kirk; Douglas A Hale; Roslyn B Mannon; David E Kleiner; Steven C Hoffmann; Robert L Kampen; Linda K Cendales; Douglas K Tadaki; David M Harlan; S John Swanson
Journal:  Transplantation       Date:  2003-07-15       Impact factor: 4.939

View more
  1 in total

Review 1.  The applications of bone marrow-derived stem cells to induce tolerance and chimerism in organ transplantation.

Authors:  M Ebrahimi; N Aghdami
Journal:  Int J Organ Transplant Med       Date:  2010
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.